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Many organic molecules of modest size and complexity have chirality.

That is,

these molecules can exist in more than one stereoisomeric form. There is a strong desire to
synthesize chiral compounds that exist in the form of a single stereoisomer. The method of
synthesizing chiral compounds that was studied in our research employed a less than
stoichiometric amount of chiral catalyst to both catalyze and control the stereochemical
outcome of the reactions attempted.
A new chiral ligand was developed to be used as part of the chiral catalyst. This
new ligand was used in the enantioselective
enantioselective

allylation

enantiomeric purity.

reaction

Diels-Alder cycloaddition reaction and the

in the attempt

to synthesize

products

of high
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I.

Introduction

As a consequence of the tetrahedral nature of carbon, most organic molecules of
even modest complexity are chiral; that is, they can exist in two mirror image
( enantiomeric) forms. In the case of pharmaceuticals and agrochemicals, one enantiomer of
the compound is often largely responsible for the desired biological activity of the
substance. Furthermore, harmful side-effects arc sometimes associated with the "wrong"
enantiomer.L? It is now recognized that in most cases single enantiomer drugs and
agrochemicals will be the standard for the industry. Therefore, efficient, reliable, general
synthetic methods for the synthesis of enantiomerically pure compounds are needed.
A number of approaches toward asymmetric synthesis have been defined.3.4
Among these, methods to synthesize compounds in high yield and high enantiopurity from
achiral starting materials have long attracted interest.5,6,7,8,9 Two general approaches have
been defined. One employs a chiral reagent in stoichiometric amounts to control the
stereochemical course of the reaction. The second approach, the one that is commonly
exploited in nature through the use of enzymes, employs a sub-stoichiometric amount of a
chiral catalyst to both catalyze and control the stereochemical course of the organic reaction.
The latter approach, termed enantioselective or asymmetric catalysis, is a rapidly growing
field of research.
The advantages of the enantioselective catalysis approach are clear. Catalytic versus
stoichiometric amounts of chiral reagent lowers the cost. In theory, it is possible to recover
and reuse the chiral catalyst. Fewer side products should be formed compared to
stoichiometric reagents thus reducing the amount of waste generated by the reaction. The
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only disadvantage of asymmetric catalysis is that it proves difficult to design efficient
catalysts and predict the stereochemical outcome. In part the difficulty lies in the lack of
mechanistic detail known for the catalyzed reaction. I Furthermore, there are no welldefined general rules for the design of efficient chiral catalysts. I In the Takacs research
group, the research on enantioselective catalysis seeks to develop efficient chiral metal
catalysts for a variety of organic reactions. Although to date there is no general set of
design requirements for such catalyst systems, several attempts to define appraoaches have
been made.
Ito suggested two requirements that should be met in order to achieve a highly
enantioselective reaction when using chiral metal catalysts I 0: l) The prochiral center that
undergoes reaction in the achiral substrate should be held close proximity to the chiral metal
center. A prochiral molecule is defined as an achiral molecule possessing enantiotopic
groups or faces. An example relavent to our studies is the aldehyde shown in Figure 1.
The aldehyde is planar and the two sides or faces of the pi-system are reflected through the
plane. 2) The reacting substrate should have two coordination sites and form a chelate
complex with the chiral metal in the enantiodifferentiating transition state. Chelation of the
reacting substrate about the central metal reduces the number of degrees of freedom (i.e.
free rotation) in the transition state, and as a consequence, it becomes easier for the
asymmetric environment imposed by the chiral ligand to be translated to control of the
stereochemistry of the product.

3
Figure 1. Prochirality and chelation.
The enantiotopic faces of an aldehyde

The formation of a metal chelate
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A third design criterion, championed by Whitesell, advocates the use of chiral
ligands possessing a C2 axis of symmetry. I I

c2-symmetry

is present when simple rotation

about an axis passing through the molecule by a 180° angle gives a structure that is identical
to the structure prior to the rotation. Ligands possessing C2-symmetry, it is argued, have
fewer diastereomeric modes of complexation, and thus reduce the number of possible
competing diastereomeric transition states. I I With fewer competing diastereomeric reaction
pathways, it is reasonable that products may be formed with higher enantioselectivity.

An

example of a famous C2-symmetric ligand is the 2,3-0-isopropylidene-2,3-dihydroxy-l
bis(diphenyl-phosphino )butane (DIOP) ligand 1 developed by Kagan and coworkers.R
DIOP was the first chiral ligand to achieve high selectivity for one enantiomer over the
other in a hydrogenation reaction.

Figure 2. A C2-symmetric ligand, the bis-phosphine DIOP.

Me)<.Me

HhH
0

Ph2P

0

PPh2

1 (DIOP)

rotate 180 °

,4-
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By way of definations, the excess of one enantiomer over the other is described by
the ratio of R:S, or more commonly by the percent optical purity(% o.p.) or equivalently
by the percent enantiomer excess(% ee). The formula for calculating the percent optical
purity is: % o.p.

= [~]o of the mixture

of enantiomers I [~]o pure enantiomer x 100 %),

with [~]o being the specific optical rotation. The formula for calculating the per cent
enantiomeric excess is % e.e. = I R - S I I ( R + S ), with R being the amount of the R
enantiomer and S being the amount of the S enantiomcr.13 The DIOP ligand was used for
the hydrogenation of a double bond to a single bond as shown in Scheme l. An % ee of
90 % was obtained at the time, even more efficient catalysts have since been discovered.

Scheme l. The asymmetric effect of DIOP (1) and other C2-symmetric chiral ligands.

Rh (I)

80 % optical yield
92 % chemical yield

A second example of a C2-symmetric ligand that has afforded interesting results is
the chiral aza-sernicorrin ligands developed by Pfaltz and coworkers.!" As illustrated
below. ligand 2 was used in the catalysis of the efficient asymmetric cyclopropanation of
alkenes such as styrcne.l+ These reactions proceed in high enantiomeric excess, 94 % ee
for the trans-diastereomcr.

The ligand is C2-symmetric, chelates to the catalytic metal

center through the nitrogens, and has a substituent alpha to the nitrogen that points toward

5
the metal center defining a chiral environment at the metal center. The substituent on the
carbon alpha to the nitrogen is thought to have a strong influence on any chirality generated
in the reaction product. This is because the chiral group blocks the approach of other
molecules from that one side. Note that the ligand is relatively rigid and this characteristic
may further suppress the number of conformations available to the reaction transition state.

R = CMe20SiMe3
Cu(l)OTf

80 % yield

trans I cis 75 I 25

% e.e. of trans diastereomers = 94 %
% e.e. of cis diastereomers = 68 %

These two examples illustrate the design concepts defined by Ito and by Whitesell
and serve to acquaint the reader with the very active field of enantioselective catalysis,
which is the general field of this thesis. Furthermore, the Pfaltz ligand is structurally
related to the ligands examined in the course of this research as described in the following
section of this thesis. The precise chemical reactions investigated however were quite
distinct. A new, bidentate nitrogen ligand was synthesized and its effectiveness in
promoting asymmetric Diels-Alder cycloaddition and allylstannane additon reactions with
zinc triflate, copper triflate, and magnesium triflate was investigated. A detailed rationale
for its synthesis and the results obtained with this new ligand are described below.
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II.

Results and Discussion

This research deals with the challenges of enantioselective catalysis. A new,
bidentate nitrogen ligand was synthesized. Its design was based on the postulate that while
the known chiral bidentate bisoxazoline ligands reported to date are Cz-symmetric as the
free ligand, their metal complexes lack C2-symmetry because the nitrogen-to-nitrogen
distance is too close. The new ligand is constrained to a bigger bite angle. Two chemical
reactions that are susceptible to Lewis acid catalysis were chosen to evaluate the efficacy of
the chiral Lewis acid complexes formed by complexing the ligand to magnesium-, zinc- and
copper triflate salts. The results obtained in the Diels Alder cycloaddition reaction between
cyclopentadiene and a chelating dienophile (the N-acyloxazolidinones derived from acrylic
and crotonic acids) will be discussed first. Later in this section, the corrresponding chiral
Lewis acid catalyzed reaction of benzaldehyde with allyltributylstannane will be discussed.

Enantioselective

Diels-Alder Cycloaddition

Reactions.

The Diels-Alder

reaction (shown in Equation l) has long been an important carbon-carbon bond forming
reaction. There are two new carbon-carbon single bonds formed resulting in a new six
member ring, a new carbon-carbon double bond, and up to four new stereocenters at the
atoms where the carbon-carbon bonds are formed (Equation I). In normal electron demand
Diels-Alder reactions (the type we will be discussing below), the diene will have an
electron donating group(s) and the dienophile will have an electron withdrawing activating
group(s).

7
Equation I. The Diels-Alder cycloaddition reaction and its potential sites for stereochemical
control.

A
~
+
~

B

A

f

...

¢::
A

A

In the Diels-Alder reaction of cyclopentadiene with an unsymmetrical dienophile,
two stereoisomeric modes of cycloaddition are possible. In the example shown below in
Equation 2, these stereoisomeric products differ with respect to whether the dienophile
activating substitutent, X (e.g., X

= C02H,

N-acyl oxazolidinone, or other carbonyl

derivative) ends up in the endo or exo orientation within the bicyclic ring system. The two
addition modes have been termed endo and exo. It has been observed that the endo product
generally forms in greater amounts than the exo product. I 3, 15 The endo mode is favored
over the exo mode by secondary orbital overlap of the pi bonds within the transition state.

Equation 2. Endo and exo product formation in the Diels-Alder reaction.

endo

X

major

exo

H

minor

In normal electron demand Dicls-Alder reactions, Lewis acids catalyze the reaction
permitting the reaction to be carried out by allowing the reagents to react under milder,
even very low temperature (-100 °C) conditions. Lewis acid catalyzed reactions often have
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the added benefit over thermal conditions of improving the endo selectivity of the
reaction.13.15 The catalysts presumably complex to a Lewis basic site on the dienophilc
(usually, the carbonyl oxygen). N-acyloxazolidinone derived from cq3-unsaturated acids
have been popular dienophiles for Diels-Alder cycloadditions, particularly in the context of
investigations into enantioselective catalysis. The reason for the popularity stems at least in
part from the fact that they form chelated complexes with bidentate Lewis acids.lv- 17 That
chelation to the Lewis acid defines the position of a (chiral) Lewis acid to the reacting sites
in the cycloaddition reaction. We have used the N-acyloxazolidinones shown below during
the course of our studies. Equation 3 shows the two enantiomeric endo products and two
enantiomeric exo products possible in the reaction of cyclopentadiene with simple Nacy loxazolidinones.

Equation 3. The possible products of this Diets-Alder reaction.
endo
exo

+

(2S)~R

(_!(

0

0 0
Ligand

+

Lewis
Acid

0 0

o~
R

Recently, Corey and Evans have developed chiral bisoxazoline-Lewis acid
complexes to catalyze the Diels-Aldcr reaction of cyclopentadicne (and certain other dienes)
with N-acyloxazolidinones (Scheme 2).18.19 Note that for simplicity only the major
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products, the enantiomeric endo isomers, are shown. There are a number of similarities
between the catalysts systems. Both systems afford high levels of endo-to exo selectivity
and as well produce the endo isomer with a high level of enantioselectivity (> 90 % ee).
Both use simple cationic metal salts as the Lewis acids and stable anion counter ions. It is
important to note that the anion must dissociate from the metal to accommodate dienophile
binding. Although the two catalyst systems use very different counter ions, they share a
common feature in that the anions arc stable and should readily dissociate as required. The
ligands employed arc also quite similar. Note that while the substituents adjacent to
nitrogen (the substituents that should provide the chiral environment about the metal center)
are different (phenyl vs tert-butyl), the absolute configurations are the same. This point
highlights the biggest difference between the two systems. The Corey catalyst gives
predominantly the 2S product; the Evans the 2R!

I0
Scheme 2. The enantioselective Diels-Alder reactions catalyzed by chiral Lewis
acids using:

a) the Corey system;

chiral Lewis acid complex 3

{o

C~o

+

0
4 eq.

0.1 eq. 3

- 80 °, 24 h.

0

/,lo o~
o~ 0

oJ-0

(25)

+

Endo:Exo
97:3

Endo
25 :2R
95.3: 4.7

82 % yield

(2R)

I 1
b) the Evans system.

Me

~o
N

+

0
5 eq.

0.08 cq. 4
- 15 °, 30 h.

~Me Mt:
(N

0

0

o~o

C 0>=o

(25)

N~

oJ-o
+

(2R)

85 % yield
Endo:Exo
96:4

Endo
2S:2R
1.5: 98.5

Scheme 3 shows the proposed models that are used to explain the stereoselectivities
observed in the reactions of Scheme 2. The difference in the 2R versus 2S sense of
stereoinduction is thought to arise from the different preferred geometries of the two chiral
Lewis acid complexes 3 and 4. Corey's model proposes a tetrahedral complex for ligand
3. The tetrahedral complex should orient the phenyl substituents so as to block approach
of the diene to the bottom face of the dienophile as drawn.lf Such an approach would lead
to formation of the 2S endo product.

I2
Scheme 3. Models for the origin of the stereoinduction observed in:

a) the Corey catalyst system;

Corey's model:
bottom side
attack favored

0

(2S)

1 3
b) the Evans catalyst system.

~

O
0)-/
(2R)

CJ

Evans' model:
top side
attack favored

"<,

'7
-

~~CMe3

o

,.o=={)

Me.._)=N..

Me~N_,c<:·o=(

v,,,,

CMe3

_)'

CJ

f .
Me

Me

<. •• ,.._

bottom side
attack
disfavored

<-1
o~

0

(2S)

The Evans model presumes a square-planar complex 4; the copper, nitrogens and
oxygen atoms all lie in the plane. In the square planar complex, the terr-butyl substituent is
oriented so as to block approach to the top face of the dienophile as drawn. The 2R endo
product would arise from such an approach.l?

It should be noted at this point that both the

Evans and the Corey model are predicated on the assumption that the C2-symmetric liagnds
will form C2-symmetric metal complexes. The question was raised by Dr. Takacs about
whether or not this had to be the case and we went to the literature to learn what was
known at the time about the structure of bisoxazoline-metal complexes.
At the time this thesis project was initiated, only one bisoxazoline-metal complex
structure was published. The complex was formed by reaction of the C2-symmetric

I4
bisoxazoline ligand 5 with zinc chloride.20 The zinc-bisoxazoline complex X has been
characterized crystallographically and reported by Carsten Bolm. Scheme 4 shows the full
crystal structure and two views of the complex shown without the attached hydrogens for
clarity. The complex has a tetrahedral geometry about the zinc atom, but is significantly
distorted from C2-symmetry. The nitrogen-to-nitrogen distance is too short to permit
binding to the metal while preserving the C2-symmetry. As shown in Scheme 4, the zinc
atom sits well below the plane defined by the nitrogens and aromatic ring. Bolm also
reported NMR studies that are consistent with two diastereomeric non-C2-symmetric
complexes in solution. In preparation for our subsequent studies, We asked the question
whether a simple molecular modeling program (MMX in PCModel v 2.1) would give
useful preliminary indications of structure for the de novo design of other ligands. Dr.
Takacs therefore performed molecular modelling studies on complex xb and found that
molecular modelling reproduced the crystal structure of complex x quite well.

1 5
Scheme 4. The Carsten Bolm C2-symmetry bisoxazoline ligand and its non-Cj-syrnmetric
zinc chloride complex.

~:>-iPr

+

N
N

;J·"

ZnCl2

'iPr

1

x

5 (R,R)

C2 axis?

90°

rotation

(aromatic ring lies in the X-Y plane)

(aromatic ring lies in the Y-Z plane)

l6

This analysis raised two new questions. ( l) Was the Corey complex

c2-symmetric

as his model required? (2) If not, could a ligand be designed that would indeed afford a
C2-symmetric zinc complex? To answer the first question, Dr. Takacs performed
molecular modeling studies on a bisoxazoline-zinc chloride complex (X) related to the one
Corey employed. The modelled structure is shown in Scheme 5. The analysis again
suggests the nitrogen to nitrogen distance is too small to bind Zn(ll) in a tetrahedral
geometry and preserve C2-symmetry. The metal may adopt a different geometry to accept
the smaller available bite angle of the bisoxazoline which is explained by the Evans model,
where the results are rationalized by a square-planar geometry.

1 7
Scheme 5. Molecular modeling of a ( 1,3)-bisoxazoline-zinc

-E-

Me

chloride complex.

C2axis?

complex X

structure obtained
by molecular modeling

rotate by 90

°

--------------~

If the Corey ligand fails to give a Cz-symmetric complex, can one be designed?
Considering molecular models it seemed plausible that a ligand based on the
bicyclo[2.2.2]-backbone could orient the nitrogens far enough apart to meet the
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requirement. Dr. Takacs carried out molecular modeling studies as shown in Scheme 6.
This analysis supported the idea that such a ligand form more nearly Cz-symmetric
tetrahedral Zn (11)-complex.

Scheme 6. Molecular modeling of a ( 1,4 )-bisoxazoline-zinc chloride complex.

complex X

structure obtained
by molecular modelling

goo

-------~
rotation

(N-Zn-N lie in X-Y plane)

(N-Zn-N lie in Y-Z plane)
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We therefore set out to design an accessible ligand based on the bicyclo[2.2.2]backbone. It should be noted that such a ligand has an additional complication compared to
the Corey or Evans ligand. That complication is that the backbone is itself chiral and
bisoxazoline ligands derived from these backbones will have a total of four stereogenic
centers that need to be controlled. Our target ligands are shown in Figure 3. The left hand
structure ( 6), in which all of the stereogenic centers are of the R absolute configuration,
will be termed the homochiral ligand. The right hand structure (7), in which the backbone
stereocenters are of the S absolute configuration and the oxazoline stereocenters of the R
absolute configuration, will be termed the heterochiral ligand.

Figure 3. Target C2-symmetric chiral bisoxazolines used in this research.

6 (homochiral)

7 (heterochiral)

The reactions to synthesize the homochiral ligand 6 are shown in Scheme 7. In this
case the initial Diels-Alder reaction employed the dimenthyl fumarate derived from Dmenthol and anthracene to form the dimenthyl ester. This reaction establishes the R,Rabsolute configuration of the backbone as required. This dimenthyl ester was treated with
base to afford the dicarboxylic acid. This dicarboxylic acid was converted to a mixed

20
anhydride via isobutyl chloroformate and base. This occured by the addition of the
carboxylate anion to the chloroester carbonyl, followed by the leaving of chlorine. The bis
mixed anhydride was added directly to a solution of (R)-phenylglycinol to afford the bis
amide alcohol. This occured by the addition of the nitrogen to the carbonyl which used to
belong to the carboxylic acid, followed by the leaving of the group containing isobutyl.
The bis amide alcohol was treated with thionyl chloride to afford the bis amide chloride.
The bis amide chloride was cyclized to form a bisoxazoline by the addition of base. This
occured by the anionic oxygen of the amide adding to the carbon containing the chlorine,
followed by the loss of this chlorine. Ligand 8 was separated by column chromatography,
75 : 25 hexane : ethyl acetate after the cyclizations of the bis-amide chloride intermediates to
form ligands 6 and 8. Bisoxazoline 8 has a R,S configuration (meso) backbone. This
meso compound comes about by epimerization during the formation and I or reaction of the
mixed anhydride. The yields are shown in the experimental section.

2 1
Scheme 7. Synthesis of the C2-symmetric homochiral bisoxazoline 6.

~ (0)
Cl+ 2""oH

0
toluene

Cl
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+
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0

0
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+
3) SOCl2
4) NaOH

(R,S)

8

(R,R)

6

A sample of the homochiral ligand was crystallized under nitrogen gas by swirling
in a minimum amount of diethyl ether. A yellow liquid was pipetted away. The remaining
solid was evaporated to dryness with nitrogen gas. This solid was then dissolved in a
minimum amount of ethyl acetate. In a vial surrounding the dissolved ligand, a similar
volume of cyclohexane was placed. This vial was wrapped with parafilm. The liquid in
the vial surrounding the ligand was replaced with fresh cyclohexane approximately every
48 hours to afford xray quality crystals after approximately 20 days. The structure was
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determined by Dr. Charles Ross using the facilities in the UNL laboratory of Professor
John J. Stezowski. The crystal of 6, along with the list of fractional coordinates, shown in
Figure 4. The structure shows the C2-symmetry of the ligand, but is somewhat surprising
in that the nitrogen-to-nitrogen distance is longer than was anticipated from molecular
modelling and Drieding model analysis.

Figure 4. Crystal structure and fractional coordinates for the homochiral ligand 6.
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In a similar fashion to that described for the homochiral ligand 6, the heterochiral
ligand 7 was prepared as shown in Scheme 8. In this case the initial Diels-Alder reaction
employed the dimenthyl fumarate derived from L-menthol and anthracene to afford the
diester. This reaction establishes the S,S-absolute configuration of the backbone as
required. This dimenthyl ester was treated with base to afford the dicarboxylic acid. This
dicarboxylic acid was converted to a bis mixed anhydride via isobutyl chlorofonnate and
base. This bis mixed anhydride was added to (R)-phenylglycinol to afford the bis amide
alcohol. This bis amide alcohol was treated with thionyl chloride to afford the bis amide
chloride. This bis amide chloride was cyclized to a bisoxazoline by the addition of base.
Ligand 8 was separated by column chromatography, 75 : 25 hexane: ethyl acetate after the
cyclizations of the bis-amide chloride intermediates to form ligands 7 and 8. Bisoxazoline
8 has a meso backbone. This meso compound again comes about by epimerization during
the formation and I or reaction of the mixed anhydride. The yields are shown in the
experimental section.

25
Scheme 8. Synthesis of the C2-symmetric heterochiral bisoxazoline 7.
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Having prepared the two desired chiral bisoxazoline ligands described above, we
turned our attention to evaluating their effectiveness in the Diels-Alder cycloadditon of
cyclopcntadiene with the IX,~ -unsaturated N-acyloxazolidinones derived from acrylic acid
and from crotonic acid. We screened three Lewis acidic metal salts in the course of our
investigation: zinc(ll)-, magnesium(II)- and copper(ll) tritluoromethanesulfonate

(triflate).

The triflates were chosen because this stable anion is known to form largely dissociated
metal complexes. We can compare the results of our study to those reported by Corey 18
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and by Evans 19 (discussed above), and in addition, we carried out parallel reactions with
the (1,3) bisoxazoline ligand 9 (purchased from Aldrich). We also decided to screen the
bisoxazoline derived from the meso diacid, ligand 8, that is formed as a side product in the
syntheses of 6 and 7. It cannot form a C2-symmetric metal complex, and we thought that
the results might prove to be an interesting comparison. A much greater quantity of the
homochiral bisoxazoline ligand 6 was synthesized than the corresponding heterochiral
ligand 7. As a consequence, the reader will notice that ligand 6 was the more highly
studied ligand. These ligands are shown below in Figure 5.

Figure 5. Chiral bisoxazoline ligands investigated in our research.
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The results of these investigations arc summarized in Table I. Several points are of
note. The reactions of Table l investigating the effect of bisoxazolines were carried out in
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dichloromethane at room temperature. We felt that in designing a new chiral catalyst, an
important goal should be to find a catalyst that is effective at higher temperatures. In our
studies, the metal-ligand complex was generated in situ allowing 45 minutes prior to
addition of substrate for precomplexing the ligand and Lewis acid. The yields of the DielsAlder reactions shown in Table 1 were determined by considering the weight of recovered
material and comparing the remaining starting material and the formation of endo plus exo
product by I H NMR integration. For the acryloyloxazolidinone system, a key starting
material proton resonates at

o 5.96 ppm and its integration

was compared to the endo plus

exo protons of the product. For the (E)-crotonyloxazolidinone system, the starting material
methyl group resonates at

o

1.97 ppm and its integration was compared to the endo plus

exo methyl groups of the product. The endo I exo ratios were also determined by 'H NMR
integration. For the acryloyloxazolidinone derived products, the endo isomer has a signal

o 3.03 ppm and the exo at o 2.94 ppm. For the (E)-crotonyloxazolidinone derived
product, the signals at o 1.15 ppm and o 0.88 ppm were integrated to assess the endo I exo
at

ratio. The 2R I 2S enantiomeric ratio of the pure endo products (separated by
chromatography, 75: 25 hexane: ethyl acetate) were determined by chiral GC on a Daicel
cyclodex-j3 column.
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a all entries were done in CH2Cl2, under N2, at room temperature, 45 minutes precomplexing the
ligand and metal triflate, 10 minutes stirring the catalyst and oxazolidinone, 15 mole% of metal triflate, 20
mole% of ligand, 8 mole equivalents of cyclopentadiene, and stirred overnight.
b the enantiomeric composition of the Diels-Alder adducts were determined by a chiral gaschromatograph (Daicel cyclodex-f3 column).
c entries done by Dave A. Quincy in the Takacs research group. These reaction yields were not
determined.
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The Corey and Evans reactions described above in Scheme 2 gave yields greater
than 82 % and the enantioselectivities were greater than 90 % ee. Our results were not as
spectacular, but nonetheless had some interesting aspects. The yields of these reactions
were greater than 78 %, except for entry 12 (magnesium triflate and ligand 6 with (E)crotonyloxazolidinone) which shows a yield of 55 %. The enantioselectivities were greater
than 43 % ee in reactions catalyzed by zinc triflate and (l,4)-bisoxazoline

ligands 6, 7, and

8. The (l ,3 )-bisoxazoline ligand 9 with magnesium triflate gave the (2R) product in 49

% ee. The most interesting example of enantioselectivity was entry 5 of Table l (copper
triflate and ligand 8 with acryloyloxazolidinone), which shows an 87 % yield, a 91 / 9
endo / exo ratio, and a 75 % ee wtih the (2R) product selectively formed. Other entries
catalyzed by copper triflate show the (2S) enantiomeric product being favored.
In order to explain the mixed results of Table l that show the (2S) or (2R) endo
enantiomer being favored by different quantitative amounts, the possible conformations of
seven atom rings should be considered. First, recall the Corey model of the approach of
cyclopentadiene to the chiral catalytic complex of the dienophile shown in Scheme 3.18
Corey shows a tetrahedral complex about the magnesium ion leading selectively to the (2R)
endo enantiomer. But Corey does not mention possible conformations of the complex.
A seven atom ring containing the catalytic metal and two nitrogens of the chiral
catalytic complex is hypothesized to exist. Seven atom rings can exist in different
conformations as shown in Figure 6.21 The twist-chair is the lowest energy conformation
of cycloheptane. But with two nitrogens and a metal in this seven member ring, its
conformation is changed. A model of the catalytic chiral complex of entry l of Table l is
shown in Scheme 9. This entry combined the homochiral ligand 6, zinc triflate, and
acryloyloxazolidinone. The catalytic metal is believed to be tetrahedral. The (Rl-phenyl
groups are one atom outside of this seven member ring alpha to each nitrogen. By
changing the catalytic metal, this changes the conformation and moves the chiral phenyl

3 I
groups to different blocking positions. Scheme 9 shows how the approach of
cyclopentadiene is favored in a way that leads to the (2R) endo enantiomer when the chiral
catalytic complex is in this conformation. Note that the bisoxazoline part of the catalytic
complex is Cj-symmetric.

Therefore if the carbonyl oxygens of the acryloyloxazolidinone

were to line up to the catalytic metal in the opposite manner, then the other phenyl group on
the bottom would do the blocking of the cyclopentadiene approach. In the case of entry 5
of Table I, the meso ligand 8 and copper triflate together produced a seven member
conformation in the catalytic complex that strongly favored the (2R) endo enantiomer being
formed in 75 % ee. Other entries of Table I produce conformations that favor the (2S)
endo enantiomer.

Figure 6. Conformations of a seven member ring.
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Scheme 9. Model for the origin of the (2R) product stereoselectivity observed with the
ligand 6-zinc catalytic complex.
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It is also hypothesized that with ( 1,3)-bisoxazolines and different catalytic metals,
different conformations of six member rings exist to produce different product
enantioselectivities.

This accounts for entries 9 through 15, where the ( 1,3)-bisoxazoline

ligand 9 and magnesium triflate catalytic complex produced six atom conformations in the
catalytic complex that led to higher product % ee's than zinc or copper triflate with ligand

9.
Furthermore, changing the amount of ligand, Lewis acid, or other conditions
changes the conformation of the catalytic complex and leads to better or worse observed
selectivities in the product formation. The change in the conformation of the catalytic
complex diagrammed in Figure 6 is longer or shorter nitrogen-metal-nitrogen bond lengths
and a bigger or smaller bite angle for the nitrogen-metal bonds.
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The results of this research investigating the Diels-Alder reaction do not appear to
compare well with the results of Corey and Evans. I 8, 19 But considering the low
temperatures used in the Corey and Evans research and that the reactions of this research
were done at room temperature, the results of this research do compare well with those of
Corey and Evans. Perhaps lower temperatures, different reaction times, different mole %'s
of ligand and I or Lewis acid, or changing other conditions could improve the selectivity
ratios observed for endo I exo isomers and for the 2S I 2R enantioselectivity of the endo
isomer. The lower temperature may slow the rate of product formation and may lead to
greater selectivity.

Enantioselective Allylations. The asymmetric allylation of aldehydes, as
shown in Scheme 1 O, is another important synthetic reaction. 22,23 Several transformations
can be performed directly from this chiral ~,'¥-unsaturated alcohol as shown in Scheme
I 0. 23.24 The chiral alcohol can be protected. The double bond can be epoxidized or
ozonolyzed. The double bond can be converted to ketone or hydroformylated to synthesize
a six-member chiral lactone. An efficient method for the enantioselective allylation of
aldehydes would be an important contribution to the field. Adding an allylstannane to an
aldehyde has been done in good(> 90 %) yield and with good(> 90 % ee)
enantioselection.23,24,25,26,27.28 Furthermore, good diastereoselection has been achieved
in the addition a crotyl stannane to aldehydes.24.29,30
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Scheme 10. The asymmetric allylation reaction and possible transformations subsequent to
the allylation.
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In our research, we attempted to allylate benzaldehyde with allyltributylstannane
using the chiral metal catalysts described above. Keck recently reported the most effective
chiral catalyst system for this allyllation.26 His method, shown in Equation 4 below uses a
combination of (R)-binaphthol and titanium tetraisopropoxide as the catalyst. Under his
optimal conditions (CH2Cli, 0 °C, 3 h) the (R)-alcohol is obtained in 94 % yield and 95 %
ee.
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Equation 4. The asymmetric allylation reaction catalyzed by (R)-binaphthol-titanium
tetraisopropoxide using the Keck system.

OH

0

o':

+
TI(Oi-Pr)4
CH2Cl2, 0 °C

~
(R, 95 % ee)

Our results are summarized in Table 2. The racemic l-phenyl-3-buten-l-ol

was

prepared via the Lewis acid catalyzed allylation in the absence of chiral ligand. The
reactions were run by generating the chiral complex in situ. It is postulated that the chiral
complex catalysts using the ( 1,4 )-bisoxazoline, ligands 6 through 8 would generate greater
enantioselectivity than the (l ,3)-bisoxazoline, ligand 9, again because of the wide bite
angle of the bisoxazoline ligands. The aldehyde and allylstannane were added after
sonicating a mixture of ligand and metal tritlate at 0 °C for 30 minutes. The enantiomeric
ratio was determined via the method described by Keck.25 Two protons of both Rand S
enantiomers were found to shift selectively in the presence of 25 mole % chiral shift reagent
Eu(hfc)3. A example of the NMR shift experiment is shown in Figure 7.
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Figure 7. Determining the enantiomer ratio of l-phenyl-3-buten-l-ol catalyzed by ligand 6
via NMR shift reagents .
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Zinc triflate was the only metal salt that we found to afford allylation product in our
screen. Other Lewis acids that were attempted were Cu(OTf)2, Mg(OTf)2, and ZnCI2. In
each of these latter cases, product was formed in a yield of less than 5 % (determined by
proton NMR of the crude reaction mixture). We attempted to use allyltrimethylsilane in the
place of allyltributylstannane, but the product was formed in a yield of less than 5 %.
Apparently, the allyltributylstannane is a stronger nucleophile than allyltrimethylsilane.
This has also been observed by Mayr and Yamamoto. 23.31
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Table 2.

(S)

-

The effect of (R)-phenyl bisoxazolines plus zinc triflate

chiral catalytic complex on the allylation reaction.

ligand

% yield

%eeb

[IX]o (0)

cC

9

66

26

+ 11.2

4.60

2

7

86

31

+ 11.6

2.60

3

6

90

39

+ 13.2

2.50

4

8

70

44

+ 13.7

1.56

entrya

a all entries were done in CH2Cl2. under N2. 25 mole % Zn(OTf)2. 25 mole % ligand, 30
minutes sonication, addition of benzaldehyde at 0°C. stir for I 0 minutes, addition of I. I mole equivalent
stannane, and stirred at room temperature for 3 hours.
1
b this was determined by H NMR of purified product with 25 mole % Eu(hfc)3, chiral shift
reagent, reference 25.
c benzene was the solvent used for the specific optical rotation.

Our research shows that the zinc triflate-bisoxazoline complex catalyzes the
allylation in a slightly enantiomerically enriched manner. Since the allylation reaction
products directed by ligands 6, 7, 8, and 9 gave positive specific rotations, it was clear
that the (R) enantiomer had been selectively formed because the (S)-1-phcnyl-3-buten-l-ol
enantiomer gives an (tX]o = - 44.92° (c

= 7.38, benzenej.t-

The chiral complex blocks the
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approach of the ally! metal toward the aldehyde in such a way that leads to the (R)
alcohoJ.14.23.24.33
The yields of both of these allylation systems were between 66 and 98 %. But
comparing the% ee's of Keck's system (87-96 % ee) to our zinc triflate-bisoxazoline
catalytic system (26-44 % ee), the Keck system clearly shows a much greater
enantioselectivity than the bisoxazoline system employed in this research, and this is
preferable. 26
This investigation indicates that more research is needed in order to increase the
% ee of this allylic alcohol product of this reaction using these bisoxazoline ligands.
Perhaps changing the reaction temperature, the mole % of ligand and I or zinc triflate, or
other conditions could improve the enantioselectivity of this reaction, as mentioned
previously.
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III.

Conclusions and Future Directions

The bisoxazoline ligands 6, 7, 8, and 9 that were investigated show potential for
being used as chirality generating agents in carbon-carbon bond forming reactions. This
research indicates that greater enantioselcctivities are observed for the Diels-Alder reaction
than the allylation reaction using these bisoxazoline ligands. The (1,4)-bisoxazoline
ligands generated up to 75 % ee in the reactions that they catalyzed.
The chiral phenyl part of the ( l ,4)-bisoxazoline (i.e. the outer part of the ligand) is
the greater stereochemistry inducing part of the ligand, compared to the "backbone" (i.e.
the inner part of the ligand derived from anthracene ). This statement is based on the % ee
of the products resulting from the allylation reactions catalyzed by ligands 6, 7, and 8
shown in Table 2, there is only small difference in % ee (31 through 44 % ee ). The (R)- lphenyl-3-butene- l-ol product was the major enantiomer of the reactions catalyzed by
ligands 6, 7, 8 and 9. If the product stereochemistry was derived mainly from the inner
part of these ligands, some (S) product enantioselection would be observed.
In the case of the asymmetric Diels-Alder reactions catalyzed by ligands 6, 7, or 8
with zinc, copper, or magnesium shown in Table 1, the conformation that the backbone
(inner part) of the ligands and metal are held strongly influences the (2R) versus (2S)
enantioselectivity and the magnitude of% ee. However, the (R)-phenyl groups alpha to the
nitrogens binding the catalytic metal are believed to block the approach of cyclopentadiene
and direct the stereochemical outcome of the product as was shown in Scheme 9.
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Also note in the asymmetric allylation reactions of Table 2 that the (1,4)bisoxazoline ligands 6, 7, and 8 did generate greater% ee's (31 through 44 % ee) than the
(1,3)-bisoxazoline ligand 9 (26 % ee).
Zinc triflate had a greater ability to catalyze the enantioselective allylation reaction
than other Lewis acids attempted (Cu(OTf)2, Mg(OTf)z, and ZnCl2). All of the Lewis
acids that were attempted to catalyze the asymmetric Diels-Alder reaction (Zn(OTf)z,
Cu(OTf)2, and Mg(0Tf)2) were able to do so. The asymmetric Diels-Alder reaction was
more easily catalyzed than the asymmetric allylation reaction.
A conformational analysis of each of the (l ,4)-bisoxazoline ligands 6, 7, and 8
with ionic zinc and with copper (II) should be performed in order to determine the
differences in the conformations of the seven member rings of these catalytic complexes
that exist.
Alternative ligands worth trying would be ( 1,4)-bisoxazolines, ligands 12 and 13,
with the cyclopropyl backbone as shown in Scheme 11. Ligands 12 and 13 could be
made from compounds 10 and 11 by the same technology used to synthesize ligands 6
and 7 from 9,10-ethane-11,12-dicarboxylic

acid-9,10-dihydro anthracene. Both the (R,R)

and (S,S) enantiomers of caronic acid, compounds 10 and 11 respectively, show a greater
magnitude of specific optical rotations than both of the enantiomers of the dicarboxylic acid
derived from anthracene. Therefore, it is postulated that the ligands 12 and 13 would have
a greater chiral environment and would thus direct reactions with greater enantioselectivity
than ligands 6 and 7. These ligands which would be derived from caronic acid would also
have the same advantage of having a large bite-angle that the anthracene derived ligands
studied in this research have.
Compound 10 was synthesized in this research, as shown in Scheme 12. The
ylide of isopropyltriphenylphosphonium

iodide was added to the dirncnthyl fumarate

derived from D-mcnthol to afford a crude dimenthyl ester. This reaction occured by the

4 l
negatively charged carbon of the ylide adding to the conjugated ester in the Michael
fashion. The other carbon, that was part of the carbon-carbon double bond of dimenthyl
fumarate and not bonded to the ylide, became negatively charged and then added to the
carbon containing the phosphonium followed by the loss of triphenylphosphine.

The crude

diester was crystallized in 100 % ethanol to establish the R,R-absolute configuration of the
backbone as required. This dimenthyl ester was treated with base to afford the dicarboxylic
acid (caronic acid), compound 10.
The reactions to synthesize compound 11, as shown in Scheme 12, occured via the
same mechanisms as with the synthesis of compound 10. The ylide of
isopropyltriphenylphosphonium iodide was added to the dimenthyl fumarate derived from
L-menthol to afford a crude dimenthyl ester. The crude diester was crystallized in l 00 %
ethanol to establish the S,S-absolute configuration of the backbone as required. This
dimenthyl ester was treated with base to afford the dicarboxylic acid (caronic acid),
compound 11.
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Scheme 11. (l ,4 )-Bisoxazolines worthy of being synthesized and attempted to be used as
chirality inducing ligands.
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Scheme 12. Synthesis of Cz-symmetric compounds 10 and 11.
+
Ph3P-CH(CH3)2 I

+

nBuLi

THF

Ph3P=C(CH3)2

,,,C02Menthyl

<.,

+

(D)-DiMenthyl
Fumarate

,,,C02H

Na OH

<.
10

><f

co2Menthyl
Na OH

.. ,'C02Menthyl

11

Also worth synthesizing would be (l,4)-bisoxazoline

ligands derived from (S)-

phenylglycinol to determine if opposite and equal (or better) enantioselcctivity would be
obtained. For example, the (R) homochiral bisoxazoline ligand 6 would not necessarily
give equal and opposite sense of asymmetric induction as the enantiomeric (S)-phenyl
homochiral bisoxazoline ligand. Only (R)-phenylglycinol was used to synthesize the
ligands for this research. Clearly, more research is needed to synthesize other ( 1,4 )bisoxazoline ligands, also to investigate these ligands in some carbon-carbon bond forming
reactions in order to determine just how effective the bisoxazolines can be when used in
asymmetric catalysis complexes.
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Research in the field of enantioselective catalysis should continue to grow with the
purpose of increasing stereosclectivitics of carbon-carbon bond forming reactions and
synthesizing enantiomerically pure compounds. To do this, a design for a ligand capable
of catalyzing organic reactions will be needed. Research chemists should continue to look
for a more generalized system for selectively catalyzing more than one kind of reaction.
Making large amounts of chiral product from achiral starting materials and a small amount
of chiral catalyst, which can be recovered and used again, would be beneficial and cost
effective.1.2.10.11.32.34
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IV.

Experimental Procedures

General procedures. Unless otherwise noted, all reactions were carried out
under an atmosphere of nitrogen, all reactions were run at ambient temperature, all
temperatures were measured externally, and all temperatures were reported in degrees
Celsius (°C).

Solvents and Reagents. Tetrahydrofuran (THF) was distilled under nitrogen
from sodium benzophenone ketyl prior to use.
distillation.

Dichloromethane

Hexanes (Hex) were purified by

(DCM) was passed through a column of alumina.

Butyllithium (n-BuLi) was used as a 2.5 M solution in hexanes.

n-

All other reagents and

solvents received from commercial sources were used without further purification.

Analytical Instrumentation and Data. Melting points were uncorrected.
Optical rotations were measured using I 0 cm cells on a Rudolph Autopol III polarimeter at
ambient temperature.

Thin layer chromatographic

(TLC) analyses were performed on

Analtech Silica Gel HLF (0.25 mm) precoated analytical plates and visualized by using a
hand-held short wavelength ultra-violet lamp (254 nm) or iodine chamber. All I H and 13C
NMR spectra were obtained on a GE Omega 300 MHz spectrophotometer.

Unless

otherwise noted, all NMR spectra were obtained on solutions in CDCl3. All I H spectral
data are reported in ppm from an internal standard tetramethylsilane or residual chloroform
as follows: chemical shift, multiplicity (s =singlet, d

= doublct,

t = triplet, q =quartet, m =

multiplet), integration, coupling constant (reported in Hertz), interpretation.
spectra were decoupled with waltz-16 decoupling.

All 13C

For most compounds, the number of

attached hydrogens were determined using the DEPT pulse sequence. All 13C spectral data
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(s

= no attached

hydrogens, d

= CH, t = CH2, q = CH3)

were reported in ppm from an

internal standard CDCl3 unless otherwise noted. Infrared (IR) spectra were obtained on a
Analect RFX-65 Ff-IR spectrophotometer using the Attenuated Total Reflectance technique
(ATR, neat, ZnSe crystal).

Selected absorbances were reported in wavenumber (crrr

! ).

Analytical samples were purified by chromatography on silica followed by a high-vacuum
drying pistol over P205. Combustion analyses were performed by M-H-W Laboratories
(Phoenix, AZ).

O c)L)
Cl

+

Cl

0

Preparation

toluene

OH

·

I

(L)
MenthylO

/"'--

of (L)-dimenthyl

O

/
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(L)
OMenthyl

0

fumarate

by the procedure

of Scharf,

reference 35, [BEJ-1-21 ]. To a solution of (Li-menthol (61.5 g, 394 mmol) in toluene
(200 mL) was added fumaryl chloride (21.5 mL, 0.20 mol). The resulting mixture was
heated to reflux. After 12 h reflux, the reaction mixture was cooled and pyridine ( 40 ml.,
0.5 mol) added. The resulting mixture was refluxed for an additional hour, then cooled to
room temperature. The mixture was washed sequentially with saturated aqueous NaCl (2 x
100 mL), 10 % aqueous HCl (2 x 100 ml.), and again with saturated aqueous NaCl (2 x
l 00 mL). The organic layer was dried (MgS04), filtered, and concentrated.

Bulb-to-bulb

distillation (210 °C, < 0.1 torr) yielded (L)-dimenthyl fumarate (59.6 g, 77 % yield) as a
pale yellow solid:

mp 57-59 °C[literature36 mp 59-61 °C];

[ex lo

= - 99.9° (c = l .40,

CHC13) [literature37 [cx]o = - 96.2° (c = l.37, CHCl3)]; IH NMR & 6.81(s,2H, C=C-H),
4.78 (ddd, J = 4.4, 4.4, 10.9 Hz, 2H, 0-C-H), 2.03 (m, 2H, CH-iPr), l.86 (rn, 2H,
CH2-CH-CH3),

l.68 (m, 4H, CH2-CH-iPr),

cH2-CH2-CH-iPr),
cH3); 13C NMR

s

l.43 (m, 41-1, CH2-C-O),

0.90 (m, 14H, CH3-CH-CH3),

l.04 (m, 4H,

0.75 (d, J = 6.9 Hz, 6H, CH2-CH-

165.3 (s, C=O), 134.5 (d, CH-C=O), 76.0 (d, 0-C-H), 47.7 (d, CH-

iPr), 41.4 (t, CH2-CH2-CH-iPr),
CH-CH3), 24.0 (t, CH2-CH-iPr),
16.9 (q, Cil2-CH-CH3).

34.8 (t, CI-12-C-O), 32.0 (d, CHMe2), 26.9 (d, CH222.6 (q, CH3-CH-CH3), 21.4 (q, CH3-CH-CH3),

0

w (~

Cl
+

Cl

2
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0
toluene
.,'OH

/

I

(D}
MenthylO

0

(D}
OMenthyl

0

(D)-Dimenthyl fumarate [BEJ-I-20] was prepared from (D)-menthol (61.5 g,
394 mmol) similarly using the procedure described above to afford (D)-dimenthyl fumarate
mp 57-59 °C; [CX]o = + 99.4° (c = 1.39,

(74.4 g, 96 % yield) as a pale yellow solid:
CHC13); I H NMR

s

6.82 (s, 2H, C=C-H), 4.79 (ddd, J = 4.4, 4.4, 10.9 Hz, 211, 0-C-

H), 2.04 (m, 2H. CH-iPr), l.86 (m, 2H, CH2-CH-CH3),

l.67 (m, 4H, Cll2-CH-iPr),

I.43 (rn, 4H, CH2-C-O), l.02 (m, 4H, CH2-CH2-CH-iPr),
CHJ), 0.75 (d, J
CH-C=O),

= 6.9 Hz, 6H, CH2-CH-CH3);

13C NMR

0.90 (m, 14H, CH3-CH-

s

165.3 (s, C=O), 134.5 (d,

76.0 (d, 0-C-H), 47.7 (d, CH-iPr), 41.4 (t, CH2-CH2-CH-iPr), 34.8 (t,

CH2-C-O), 32.0 (d, CHMe2). 26.9 (d, CH2-CH-Cl-13), 24.0 (t, CH2-CH-iPr),
CH3-CH-CH3), 21.4 (q, CH3-CH-CH3),

22.6 (q,

16.9 (q, CH2-CH-CH3).

0
+

(D} /

I

MenthylO
0

Preparation

(D}
OMenthyl

AIC13
toluene

of (R,R)-9,10-ethane-11,12-dimenthyl

carboxylate-9,10-

dihydro anthracene by the procedure of Yamamoto, reference 38, (prepared
by KLR-I-38).

A mixture of aluminum trichloridc ( 10.64 g, 80.0 mmol), anthracenc

(7.30 g, 40.8 mmol), and toluene (350 rnl.) was stirred at O 0C. (0)-Dimenthyl fumarate
(16.0 g, 40.8 mmol) was added, solution was brought to room temperature, and stirred for
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4.5 hours. The resulting mixture was quenched with water ( 100 mL). Ethyl acetate (200
mL) was added and the mixture stirred for 24 hours. The organic layer was then washed
sequentially with saturated aqueous NaCl (2 x 100 mL), 10 % aqueous NaOH ( 100 mL),
and saturated aqueous NaCl ( 100 mL). The organic layer was then dried (Na2S04),
filtered, and concentrated. The resulting white solid was recrystallized from ethanol to give
(R,R)-9,10-ethane-11,12-dimenthyl

carboxylate-9,10-dihydro

anthracene (18.0 g, 77 %

yield) as a white solid: mp 166-167 °C [C<]o = + 29.4° (c = 4.99, CHCI)); IH NMR

o

7.37 (rn, 21-1), 7.23 (rn, 2H), 7.12 (m, 4H), 4.72 (s, 2H, CH-Ar), 4.60 (ddd, J = 4.4,
4.4, 10.9 Hz, 2H, O-C-11), 3.40 (s, 2H, CH-C=O), 2.00 (m, 2H, CH-iPr), 1.84 (m, 21-1,
cH2-CH-Cll3),

1.43 (m, 4H, CH2-C-O), 0.98 (m, I 8H),

l.70 (m, 4H, CH2-CH-iPr),

0.76 (d, J = 7.2 Hz, 6H, CI-12-CH-CH3); 13C NMR

s

172.6 (s, C=O), 143.2 (s), 140.8

(s), 127.0 (d), 126.7 (d), 125.5 (d), 124.2 (d), 75.7 (d, 0-C-H), 48.9 (d), 47.7 (d), 47.6
(d), 41.4 (t, CI-l2-CH2-CH-iPr),
CH-CI-13), 23.8 (t, CH2-CH-iPr),

34.9 (t, CH2-C-O),

32.0 (d, CHMe2), 26.7 (d, CH2-

22.6 (q, CH3-CH-CH3), 21.7 (q, CH3-CH-CH3),

16.8 (q, CH2-CH-CH3).

(L)

+

OMenthyl

(L)

AICl3

MenthylO

0

toluene

(S,S )-9, 1O-Ethane-11,12-dimen
anthracene (prepared by KLR-1-21-2).

thy I

carboxylate-9,

10-dihyd ro

The cycloadduct was prepared from (L)-

dimenthyl fumarate (5.66 g, 14.4 mmol) using the procedure described above to afford
(S,S)-9,10-ethane-ll,12-dimenthyl carboxylate-9,10-dihydro

anthracene (5.89 g, 71 %

yield) as a white solid: mp 168.5-170 °C; [C< Jo = - 30.0° ( c = 5.02, CI-ICl3); I H NMR

o
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7.38 (m, 2H), 7.23 (m, 2H), 7.12 (rn, 4H), 4.71 (s, 2H, CH-Ar), 4.59 (ddd, J = 4.4,
4.4, 10.9 Hz, 2H, 0-C-H), 3.40 (s, 21-1, CH-C=O), 2.00 (m, 2H, CH-iPr), 1.82 (m, 2H,
CH2-CH-CH3),

1.67 (m, 4H, CH2-CH-iPr),

0.77 (d, J = 6.9 Hz, 6H, CH2-CH-Cil3);

1.43 (m, 4H, Cl-12-C-O), 0.98 (rn, 18H),

13C NMR d 172.6 (s, C=O), 143.2 (s), 140.8

(s), 127.0 (d), 126.7 (d), 125.5 (d), 124.2 (d), 75.7 (d, 0-C-H), 48.9 (d), 47.7 (d), 47.6
(d), 41.4 (t, CH2-CH-iPr),

34.9 (t, CH2-C-O), 32.0 (d, CHMe2). 26.7 (d, CII2-CH-

cH3), 23.8 (t, CH2-CH-iPr), 22.6 (q, CH3-CH-CH3),

21.7 (q, CH3-CH-CH3),

16.7 (q,

CH2-CH-CH3).

0.6 N NaOH

Preparation

of

(R,R)-9, 1O-ethane-11,12-dicarboxylic

acid-9, 10-

dihydro anthracene by the procedure of Matsuda, reference 37, [BEJ-11-24].
A mixture of (R,R)-9, 10-ethane-l l, 12-dimenthyl carboxylate-9, 10-dihydro anthracene
(9.60 g, 16.8 mmol) and 170 mL of 0.6 N sodium hydroxide (4.0 g, 100 mmol) in 9:1
ethanol :water was heated to reflux.

After 16 hours, the mixture was concentrated via

rotovap, then diluted with water ( 100 mL) and further concentrated.

The residue was

slurried in water ( 100 mL) and some liberated white solid (menthol) separated by filtration.
The filtrate was acidified with hydrochloric acid until pH < 2, then extracted with diethyl
ether (3 x 75 mL). The combined organic extracts were dried (MgS04), filtered, and
concentrated. The residue was recrystallized from acetonitrile to give (R,R)-9, IO-ethane11, 12-dicarboxylic acid-9, I 0-dihydro anthracene (3.13 g, 63 % yield) as a white powder:

5 1
mp 253-254.5 °C [Iiteraturc '? mp 252.5 °C]; [~lo=+
[Iiteraturc l? [~]578
2H,

co2H),

=+

12.1° (c

= 5.22.

l,4-dioxane)

l l.7° (c = 5.00, 1,4-dioxane)]; 1 H NMR (acetone-dx)

o

10.87 (s,

7.39 (s, 2H), 7.29 (s, 2H), 7.09 (m, 4H), 4.83 (s, 2H, CH-Ar), 3.38 (s,

2H, CH-C=O); 13C NMR (acctone-ds)

o

173.5 (s, C=O), 143.6 (s), 141.6 (s), 126.8 (d),

126.7 (d), 125.5 (d), 124.2 (d), 48.2 (d), 47.3 (d); Ff-IR (ZnSe, ATR) 2962, 1705 cm-I.

0.6 N NaOH
9 EtOH: 1 H20

(S,S)-9, 1O-Ethane-11,12-dicarboxylic

acid-9, 10-dihydro

[BEJ-11-8] was prepared from (S,S)-9,10-ethane-l

l,12-dimenthyl

anthracene

carboxylate-9,10-

dihydro anthracene (8.40 g, 14.7 mmol) using the procedure described above to afford
(S,S)-9, 10-ethane-l l , 12-dicarboxylic acid-9, 10-dihydro anthracene (2.28 g, 53 % yield)
as a white powder: mp 252-253.5 °C [literature-? mp 252.5 °C]; [~]o = - 5.05° (c
1,4-dioxane) [literature39 [~]578

=-

15.3° (c

= 2.00,

= 2.06,

1,4-dioxane)]; IJ-1 NMR (acetone-dx)

0 10.67 (s, 211, C02H), 7.39 (s, 2H), 7.29 (s, 2H), 7.09 (m, 4H), 4.82 (s, 2H, CH-Ar),
3.38 (s, 211, CH-C=O); 13C NMR (acetone-dx)

o

173.4 (s, C=O), 143.6 (s), 141.4 (s),

126.8 (d), 126.6 (d), 125.4 (d), 124.2 (d), 48.2 (d), 47.3 (d); Ff-IR (Zn-Se, ATR) 2966,
1730 crrr '.
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Ph

+

(R,R)<!'IN
3) SOCl2 ;

0

4) NaOH

Preparation

of (R,R)-9, 10-ethane-11,12-((R,R)-4,4 '-diphenyl-2,2' -

(l,4)-bisoxazoline-9,10-dihydro

anthracene,

compound

6,

by

the

procedures of Pettit, reference 40 and Nishiyama, reference 41, [BEJ-11-22,
BEJ-11-26, BEJ-11-28].

To a cooled (- 5 cc) solution of (R,R)-9,10-ethane-l l,12-

dicarboxylic acid-9, 10-dihydro anthracene ( 1.00 g, 3.40 mmol) and triethylamine (0.99
ml., 7.l mmol) in THF (40 mL) was added isobutyl chloroformate (0.96 mL, 7.4 mmol).
The resulting slurry was stirred for 30 minutes (- 5 cc), then filtered directly into a solution
of (R)-phenylglycinol

( 1.0 g, 7.4 mmol) in cold (- 5 cc) THF (70 mL). The resulting

mixture was stirred and slowly warmed to room temperature.

After 16 hours, the mixture

was concentrated and the residue partitioned between DCM (75 mL) and 10% aqueous HCl
(75 mL). The organic layer was washed sequentially with 10% aqueous HCl (75 ml.),
saturated aqueous NaCl (75 ml.), and then dried (MgS04), filtered, and concentrated to
give a crude bis amide alcohol which was used without further purification.
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This crude bis amide alcohol was dissolved in DCM ( 100 mL) and treated with
thionyl chloride (4.9 mL, 67 mmol). After 15 min, the resulting solution was heated at
reflux for 3 hours and then cooled to room temperature.

The solution was washed

sequentially with cold water ( l 00 mL), 0.1 M aqueous K2C03 (2 x 120 ml.), and saturated
aqueous

NaCl ( 100 mL).

The organic

layer was dried (Na2S04),

filtered,

and

concentrated. The crude product was purified by chromatography on silica (step gradient
eluent: 98:2 Hex:EtOAc (300 ml.); 50:50 Hex:EtOAc) to give a crude bis amide chloride
which was used without further purification.
A mixture of this purified bis amide chloride and 180 mL 0.6 N sodium hydroxide
(4.3 g, 108 mrnol) in 7:3 methanol:water was heated under reflux for 4 hours. The mixture
was then concentrated to remove methanol.

Sodium chloride was added to saturate the

aqueous layer, and the resulting mixture extracted with DCM ( 4 x 90 ml.). The extracts
were washed with 2 % aqueous sodium hydroxide,

dried (Na2S04), filtered, and

concentrated. Chromatography on silica, 75:25 Hex:EtOAc, yielded the (l,4)-bisoxazoline
ligand 8 (0.189 g, 11 % yield) as a pale yellow solid and the desired (R,R)-(1,4 )bisoxazoline ligand 6 (0.358 g, 21 % yield): TLC analysis (60:40 DCM:Et20,

Iodine

chamber visualization), Rr 0. 76 (R,R)-9, l O-ethane-11, 12-( (R,R)-N ,N' -bis-(2-chloro- lphenylcthyl)-carboxamide )-9, 10-dihydro anthracene, 0.71 8, 0.64 6.
(R,S)-bisoxazoline

8: mp 87-89 °C; [~]D = + 40.6° (c = 1.06, CHCl3); IH NMR

S 7.35 (m, 4H), 7.26 (rn, 6H), 7.15 (m, 4H), 7.06 (m, 411), 4.99 (dd , J = 7.9, 9.8 Hz,
2H, Ph-CH-N),

4.82 (s, 2H, CH-Ar fused), 4.57 (dd, J = 8.6, 10.0 Hz, 2H from 2

CH2's), 4.01 (t, J = 8.0 Hz, 2H from 2 CH2's), 3.68 (s, 2H, CH-BO) ; 13C NMR

s

169.5 (s, 0-C=N), 143.2 (s), 141.1 (s), 129.2 (d), 127.2 (d), 127.0 (d), 124.5 (d), 75.9
(t), 69.9 (d, Ph-CH-N), 47.6 (d, CH-Ar fused), 43.5 (d, CH-BO); Ff-IR (ZnSe, ATR)
3024, 2962, 1657 crrr

l;

Combustion analysis (C341128N2o2

found 82.42 % C, 5.72 % H.

= 82.23 % C, 5.68 % H)
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(R,R)-bisoxazoline

6: mp 147-149 °C; [IX]o = - 27.4° (c = l.03, CHCl3); IH

NMR S 7.35 (m, 141-1), 6.50 (rn, 4H), 5.02 (t, 2H, J = 8.9 Hz, Ph-CH-N), 4.89 (s, 2H,
CH-Ar fused), 4.60 (dd, J

=

8.1, IO. I Hz, 2H from 2 CH2's), 3.97 (t, J = 8.2 Hz, 2H

from 2 CH2's), 3.93 (s, 2H, CH-BO);

13C

NMR S 169.9 (s, 0-C=N), 142.8 (s), 141.6

(s), 129.l (d), 127.l (d), 125.5 (d), 125.2 (d), 76.6 (t), 69.7 (d, Ph-CH-N),
CH-Ar

fused), 43.8 (d, CH-BO);

FT-IR (ZnSe,

ATR) 3026, 2964,

47.2 (d,

1657 crrr l:

Combustion analysis (C34H2sN202 = 82.23 % C, 5.68 % H) found 81.96 % C, 5.46 %
H.

:-(Ph

1) Et3N, Cl-C02iBu ;
2)

( R) .•fh OH ·

H2N~

I

Ph

....:::-

3) SOCl2;

4) NaOH

(S,S)

(S,S)-9, 10-ethane- l l, 12-((R,R)-4,4' -diphenyl-2,2'-(1,4

)-

bisoxazoline-9,10-dihydro anthracene, compound 7, [BEJ-11-5, BEJ-11-6, BEJ11-9]. Compound 7 was prepared from (S,S)-9, l 0-ethane-l l , 12-dicarboxylic acid-9, 10dihydro anthracene ( 1.00 g, 3.40 mmol) using the procedure described above to afford the
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( 1,4 )-bisoxazoline

ligand 8 (0.122 g, 7 % yield) as a pale yellow solid and the desired

(S,S)-(l ,4)-bisoxazoline ligand 7 (0.154 g, 9 % yield): TLC analysis (60:40 DCM:Et20,
Iodine chamber visualization),

Rf 0.76 (R,R)-9, 10-ethane-l l , 12-((R,R)-N,N'-bis-(2-

chloro-l-phenylcthyl)-carboxamide)-9,
(S,S)-bisoxazoline
NMR

s

10-dihydro anthracene, 0.71 8, 0.64 7.

7: mp 158-159.5 °C; [D:]o = - 33.2° (c = 0.99, CHCl3); 'H

7.54 (rn, 2H), 7.24 (m, 121-1), 6.49 (m, 4H), 5.02 (t, 2H, J = 9.3 Hz, Ph-CU-

N), 4.87 (s, 2H, CH-Ar fused), 4.60 (dd, J = 8.1, 10. l Hz, 2H from 2 CHi's), 3.96 (t, J
= 8.1 Hz, 2H from 2 CH2's), 3.92 (s, 2H, CH-BO);

13C

NMR

o

169.9 (s, 0-C=N),

142.8 (s), 141.6 (s), 129.l (d), 127.l (d), 125.5 (d), 125.2 (d), 76.6 (t), 69.8 (d, PhCH-N), 47.2 (d, CH-Ar). 43.8 (d, CH-BO); Ff IR (ZnSe, ATR) 2966, 2895, 1656 cm-I;
Combustion analysis (C34H2sN202 = 82.23 % C, 5.68 % H) found 82.06 % C, 5.46 %
H.

0
~H

Preparation

+~SnBua

of l-phenyl-3-buten-l-ol

by

the

procedure

of Keck,

reference 26, [BEJ-11-60]. To a cooled (- 78 °C) solution of benzaldehyde (0.12 mL,
1.2 mrnol) and allyltributyltin (0.34 mL, l. l mmol), DCM (2.0 mL), boron trifluoride
diethyl etherate (0.12 mL, 1.0 mmol) was added dropwise.
slowly warmed to room temperature.

The reaction mixture was

After 2 hours, saturated aqueous NaHC03 (4 mL)

was added and the resulting mixture stirred rapidly ( l h). DCM (20 mL) and Na2S04 was
added,

and the organic

layer was separated, dried,

filtered,

and concentrated.

Chromatography on silica (91 :9 Hex:EtOAc) yielded l-phenyl-3-buten-l-ol

(0.150 g, 84 %

yield) as a clear oil: TLC analysis (91 :9 Hex:EtOAc, Iodine chamber visualization) Rf
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0.08; IH NMR

s

7.32 (rn, 5H), 5.81 (rn, lH, CH=CH2), 5.17 (rn, 2H, CH=CH2). 4.73

(rn, lH, benzylic), 2.53 (rn, 2H,), 2.29 (s, lH, OH);

13C

NMR

o

144.6 (s, CH=CH2).

135.2 (s), 129.l (d), 128.2 (d), 126.5 (d), 119.0 (t, CH=CH2), 74.0 (d, benzylic), 44.5
(t).

endo
exo

0

0

N)lO
+

x/

\__}

X =Hor CH3

Ligand + M(OTf)2
6, 7, 8, or 9
M = Zn, Cu, or Mg

q)l_~'fb
0 0

+

x
The general procedure for the Diels-Alder reactions catalyzed by
bisoxazolines and metal triflates, [BEJ-111-17]. A mixture of ligand 6 (0.0639 g,
0.129 mmol), zinc tritlate (0.351 g, 0.0965 rnmol), and DCM ( 1.5 mL) was stirred at
room temperature.

After 45 minutes, acryloyloxazolidinone

(E)-crotonyloxazolidinone

(0.0735 g, 0.521 mmol) or

was added. After 15 minutes, cyclopentadiene (0.34 mL, 4.2

mmol) was added. After 16 hours, the mixture was concentrated.

Chloroform (2 rnl.) and

saturated aqueous NaHC03 (4 mL) were added. The organic layer was dried (MgS04),
filtered, and concentrated.

The reaction yield (93 % ) was determined by I H NMR

integration comparing the remaining starting material and the formation of endo plus exo
product. The endo I exo ratio (90 I 10) was determined by I H NMR integration. A portion
of pure endo isomers,

which was isolated

by chromatography

on silica (75:25
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Hex:EtOAc), was injected into the chiral gas-chromatograph (Daicel cyclodex-B column,
with temperature program starting at 110 °C and going to 150 °C at a rate of 0.4 degrees per
minute, and then going to 220 °Cat a rate of 2.0 degrees per minute). The 2S enantiomer
eluted at 105.5 minutes and the 2R enantiomer eluted at 105.9 minutes to determine the 2R
/ 2S (71.5 / 27.5) enantiomeric composition.

For the acryloyloxazolidinone

system, a

starting material proton occurs at d 5.96 ppm and was integrated and compared to the endo
I exo proton of the product. For the (E)-crotonyloxazolidinone

system, the starting material

methyl group occurs at d 1.97 ppm and was integrated and compared to the endo / exo
methyl group of the product. For the acryloyloxazolidinone plus cyclopentadiene product,
the signal at

o 3.03 ppm

and 2.94 ppm is the endo I exo proton and was integrated.

the (E)-crotonyloxazolidinone

plus cyclopentadiene product, the signal at

o

For

1.15 ppm and

0.88 ppm is the endo I exo methyl group and was integrated.

+
Ph3P-CH(CH3)2 I

+

THF

nBuli

Preparation of (1S,3S)-dimenthyl
reference

42, [BEJ-1-23].

To

caronate by the procedure of Krief,
a

cooled

solution

(0

°C)

of

isopropyltriphenylphosphonium iodide (15.6 g, 36.0 mmol) in THF (485 mL) nBuLi
( 14.4 mL, 36.0 mmol) was added.
This ylide solution was slowly added via addition funnel to a cooled (- 78 °C)
solution of (L)-dimenthyl fumarate ( 11.8 g, 30. l mmol) in THF (600 mL). The resulting
mixture was stirred for 30 minutes and then brought to room temperature.

The reaction

58
was quenched by the addition of 10% aqueous hydrochloric acid. The mixture was dried
(MgS04), filtered, and concentrated. Chromatography on silica (step gradient eluent :
100% Hex (300 mL); 98:2 Hex:EtOAc) yielded a crude product which was crystallized in
100% ethanol (0.1 M) and letting the solution stand overnight to give (1 S,3S)-dimenthyl
caronate (4.88 g, 37 % yield) as white crystals: mp 138-139.5 cc; 'H NMR

o 4.66 (ddd,

J = 4.3, 4.3, 11.0 Hz, 2H, 0-C-H), 2.19 (s, 2H, CH-C02CH), 1.92 (m, 4H), 1.66 (m,
4H, cH2-CH-iPr), 1.41 (m, 4H, CH2-C-O), 1.25 (s, 6H, CH3-C-CH3), 0.99 (m, 4H,
cu2-cH2-CH-iPr), 0.88 (rn, 14H, Cll3-CH-CH3), 0.74 (d, 1 = 6.9 Hz, 6H, CH2-CH-

en».

13C NMR

s

170.9 (s, C=O), 75.4 (d, 0-C-H), 47.6 (d, CH-iPr), 41.8 (t, CH2-

cH2-cH-iPr), 34.9 (t, CH2-C-O), 34.0 (q, CH3-C-CH3), 32.0 (d, CHMe2), 30.2 (s,
cH3-C-CH3), 26.7 (d, CH2-CH-CH3), 24.0 (t, CH2-CH-iPr), 22.6 (q, CH3-CH-CH3),
21.4 (q, CH3-CH-CH3), 21.0 (d, CH-C02CH), 16.9 (q, CH2-CH-CH3).

_,,C02Menthyl
(D)-DiMenthyl + Ph3 P=C(CH3) 2
Fumarate

THF

~co2Menthyl
(1R,3R)-Dimenthyl

caronate, [BEJ-1-16] was prepared from (0)-dimenthyl

furnarate (8.93 g, 22.7 mmol) using the procedure described above to afford ( 1 R,3R)dimenthyl caronate (4.54 g, 46 % yield) as white crystals: mp 137-138 cc; 1H NMR

o

4.66 (ddd, 1 = 4.3, 4.3, 11.0 Hz, 2H, 0-C-H), 2.19 (s, 2H, Cll-C02CH), 1.92 (m, 4H),
1.66 (rn, 4H, Cll2-CH-iPr), 1.42 (m, 4H, CH2-C-O), 1.25 (s, 6H, CH3-C-Cll3), 0.99
(rn, 4H, CH2-CH2-CH-iPr), 0.88 (m, 14H, CH3-CH-CH3), 0.74 (d, J = 6.9 Hz, 6H,
CH2-CH-Cll3);

13C

NMR

s

170.9 (s, C=O), 75.4 (d, 0-C-H), 47.6 (d, CH-iPr), 41.8

(t, CH2-CH2-CH-iPr),

34.9 (t, CH2-C-O), 34.0 (q, CH3-C-CH3),

30.2 (s, CH3-C-CH3),

26.7 (d, Cil2-CH-CH3),

24.0 (t, CH2-CH-iPr),

CH-CH3), 21.4 (q, CH3-CH-CH3), 21.0 (d, CH-C02CH),

><f'co

+

2Menthyl

32.0 (d, CHMe2),
22.6 (q, CH3-

16.9 (q, CH2-CH-CH3).

9 EtOH: 1 H20

NaOH
.. ,,C02Menthyl

Preparation

of (1S,3S)-caronic

of Matsuda, reference 37, [BEJ-1-26].

acid, compound

11, by the procedure

A solution of (lS,3S)-dimenthyl

caronate

(5.00 g, 11.5 mmol) and Sodium hydroxide (2.76 g, 69.0 mmol) in 9: l ethanol:water ( 100
mL) was refluxed overnight.

concentrated via rotovap.

Water (20 mL) was added to the solution and the mixture
This process was repeated four more times.

The aqueous

residue was extracted with (4 x 20 mL) ether and the aqueous layer acidified with 10 %
aqueous hydrochloric acid until pH < 2. The acidic aqueous layer was extracted with ether
( 4 x 20 mL). The combined organic layers were concentrated to give a crude product. The
crude product was dissolved in IO% aqueous sodium hydroxide and acidified with 10 %
aqueous hydrochloric acid until pH < 2. The acidic aqueous layer was extracted with ether
( 4 x 20 mL).

The combined

organic extracts were dried (MgS04), filtered, and

concentrated to give (1 S,3S)-caronic acid, compound 11, ( l.55 g, 86 % yield) as a white
powder: mp 208-209 °C; [IX]o

= + 35.8° (c =

(s, 2H, C02H), 2.08 (s, 2H, CH-C02H), l.27 (s, 6H, CH3); 13C NMR
171.8 (s, C02H), 33.8 (d), 30.3 (s), 20.3 (q).

o 9.93
(acetone-ds) s

l.98, MeOH); I H NMR (acetone-dx)

60
,,C02Menthyl
NaOH

9 EtOH: 1 H20

><lC02Menthyl +

(1R,3R)-Caronic

acid, compound

10, [BEJ-1-19] was prepared from

(1 R,3R)-dimenthyl caronate ( 4.00 g, 9.16 mmol) using the procedure described above to

afford (1 R,3R)-caronic acid, compound 10, ( 1.19 g, 82 % yield) as a white powder: mp

= - 31.5° (c = 2.00, MeOH) [literature+J
NMR (acetone-ds) o 10.23 (s, 2H, C02H), 2.08 (s, 2H,

206-208 °C [literature43 mp 208-208.5 °C]; [e<]o
[e<]546

= - 34.5° (MeOH)]; 1H

CH-C02H), 1.27 (s, 6H, CH3); 13C NMR (acetone-ds)
30.3 (s), 20.3 (q).

o

171.8 (s, C02H), 33.8 (d),

6 I

V.

(l)
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